Astle Christopher
- SEC CIK
- 0001915257
No open-market purchases or sales filed in the past year.
Current role at each company
- ZYME Zymeworks Inc.SVP & Chief Financial Officeras of Jan 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Astle Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 (view filing) | Jan 5-8 | 3 days | Astle ChristopherSVP & Chief Financial Officer | SSale | −5.99K | $10.79 | −$64.7K | −48.0%6.50K after | 2 lots |
| Dec 11, 2023 (view filing) | Dec 11 | Same day | Astle ChristopherSVP & Chief Financial Officer | SSale | −886 | $9.13 | −$8.09K | −30.7%2.00K after | |
| Dec 23, 2022 (view filing) | Dec 12 | 11 days | Astle ChristopherSVP & Chief Financial Officer | SSale | −887 | $6.01 | −$5.33K | −40.0%1.33K after | Amended |